IL-1R Blockade Is Not Effective in Patients With Hematological Malignancies and Severe SARS-CoV-2 Infection

Ann Hematol. 2020 Jun 25;1-4. doi: 10.1007/s00277-020-04160-w. Online ahead of print.

Abstract

No abstract available

Keywords: Hematological malignancies; IL-1R blockade; SARS-CoV-2.

Publication types

  • Letter